Hyaluronic Acid Joint Pain Meta-analysis: What the Evidence Says

Quick Answer

Hyaluronic Acid Joint Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Recent meta-analyses have also underscored the limited evidence regarding the comparative effectiveness of pharmacological agents during this stage, reinforcing the importance of targeted investigations such as the present study. [CHANG Chih-Ya (2026); evidence level 2]
• As shown inand, the HA group exhibited a reduction in total SPADI score from 43.03 ± 17.65 at baseline to 16.14 ± 12.77 at week 26, while the rehabilitation group improved from 51.97 ± 18.35 to 23.21 ± 21.83. [CHANG Chih-Ya (2026); evidence level 2]
• While its etiology is multifactorial - involving age, genetics, trauma, and metabolic inflammatio - overweight and obesity remain the most significant modifiable risk factors. [Wang Hao (2026); evidence level 4]
• Ultimately, the disruption of joint structural integrity significantly restricts activities of daily living and increases the risk of systemic multimorbidity, such as cardiovascular events, making KOA a leading cause of global disability in the aging population. [Wang Hao (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For hyaluronic acid joint pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• CHANG Chih-Ya (2026). EFFICACY OF ULTRASOUND-GUIDED INTRA-ARTICULAR HYALURONIC ACID INJECTION IN THE MANAGEMENT OF ADHESIVE CAPSULITIS: A RANDOMIZED CONTROLLED TRIAL. DOI: 10.2340/jrm.v58.44901. PMCID: PMC13184811. PMID: 42136070. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13184811/
• Wang Hao (2026). Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions. DOI: 10.12659/MSM.952864. PMCID: PMC13203996. PMID: 42169392. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13203996/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.